Zinc oxide nanoparticles inhibit osteosarcoma metastasis by downregulating β-catenin via HIF-1α/BNIP3/LC3B-mediated mitophagy pathway

Osteosarcoma (OS) therapy faces many challenges, especially the poor survival rate once metastasis occurs. Therefore, it is crucial to explore new OS treatment strategies that can efficiently inhibit OS metastasis. Bioactive nanoparticles such as zinc oxide nanoparticles (ZnO NPs) can efficiently in...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Guanping, Nie, Jing-Jun, Liu, Xiao, Ding, Zihao, Luo, Peng, Liu, Yu, Zhang, Bo-Wen, Wang, Renxian, Liu, Xiaoguang, Hai, Yong, Chen, Da-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112061/
https://www.ncbi.nlm.nih.gov/pubmed/35600978
http://dx.doi.org/10.1016/j.bioactmat.2022.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112061/
https://www.ncbi.nlm.nih.gov/pubmed/35600978
http://dx.doi.org/10.1016/j.bioactmat.2022.05.006

Ejemplares similares